Skip to main content
Clinical Trials/JPRN-UMIN000036550
JPRN-UMIN000036550
Completed
Phase 3

A Prospective, Multi-Center, Single Arm Clinical Study to Evaluate the MDT-1118 Ventricular Assist Device System for Destination Therapy of Advanced Heart Failure - MDT-1118 Japan DT Study

Medtronic Japan Co., Ltd0 sites10 target enrollmentApril 22, 2019

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Advanced Heart Failure
Sponsor
Medtronic Japan Co., Ltd
Enrollment
10
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 22, 2019
End Date
July 31, 2022
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1Patients with INTERMACS profile 1 2Existence of any ongoing mechanical circulatory support other than an intra\-aortic balloon pump 3Prior cardiac transplant 4History of confirmed, untreated abdominal thoracic aortic aneurysm 5 cm, ventricular aneurysm or intraventricular septum rupture 5Severe calcification in thoracic aorta 6Cardiothoracic surgery within 14 days of implantation 7Acute myocardial infarction within 14 days of implant as diagnosed by ST or T wave changes on the ECG, diagnostic biomarkers, ongoing pain and hemodynamic abnormalities as described in the guidelines published in ACCAHA 2007 Guidelines for the Management of Patients with Unstable Angina NonSTElevation Myocardial Infarction1 8Patients eligible for cardiac transplantation 9On ventilator support for 72 hours within the four days immediately prior to implantation 10Pulmonary embolus within 21 days of implantation as documented by computed tomography scan or magnetic resonance imaging (MRI)

Outcomes

Primary Outcomes

Not specified

Similar Trials